Biomarker News and Research

RSS
A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.
Recql5 identified as a tumor suppressor in GI tract

Recql5 identified as a tumor suppressor in GI tract

Biocartis closes Series 'B' equity financing round

Biocartis closes Series 'B' equity financing round

Researchers find new genomic approach to identify smokers at risk of lung cancer

Researchers find new genomic approach to identify smokers at risk of lung cancer

Aushon BioSystems introduces new multiplex biomarker Human Vascular Injury Panels

Aushon BioSystems introduces new multiplex biomarker Human Vascular Injury Panels

Avid Radiopharmaceuticals, PETNET Solutions collaborate in manufacture of Florbetapir F 18

Avid Radiopharmaceuticals, PETNET Solutions collaborate in manufacture of Florbetapir F 18

CancerGuide Diagnostics, Duke University form cancer research collaboration and licensing agreement

CancerGuide Diagnostics, Duke University form cancer research collaboration and licensing agreement

PerkinElmer expands "No Wash" ALPHA Technology portfolio

PerkinElmer expands "No Wash" ALPHA Technology portfolio

International experts recommend individualized treatment for type 2 diabetic patients

International experts recommend individualized treatment for type 2 diabetic patients

Individualized therapies for treating type 2 diabetes recommended

Individualized therapies for treating type 2 diabetes recommended

Cellvax moves to new laboratory facility in ENVA

Cellvax moves to new laboratory facility in ENVA

Metabolon awarded U.S. patents for metabolomics methods

Metabolon awarded U.S. patents for metabolomics methods

ADDF grants Signum Biosciences $270,000 for evaluating PP2A-modulatory compounds as AD therapeutics

ADDF grants Signum Biosciences $270,000 for evaluating PP2A-modulatory compounds as AD therapeutics

FDA accepts for review Abbott's novel diagnostic test for rapid detection of NGAL

FDA accepts for review Abbott's novel diagnostic test for rapid detection of NGAL

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics reports revenues of $150,000 for full-year 2009

ARQ 197 demonstrates 66% improvement in median PFS in patients with advanced NSCLC

ARQ 197 demonstrates 66% improvement in median PFS in patients with advanced NSCLC

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Two Phase I studies of Stedivaze demonstrate safety in patients with asthma and COPD

Intellikine, Tragara Pharmaceuticals awarded $1M each for developing new multiple myeloma therapies

Intellikine, Tragara Pharmaceuticals awarded $1M each for developing new multiple myeloma therapies

SMARTube technology helps physicians create index to get accurate picture of HIV infection

SMARTube technology helps physicians create index to get accurate picture of HIV infection

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

Treatment with beta-blockers can help reduce spread of cancer in patients with breast tumours

Treatment with beta-blockers can help reduce spread of cancer in patients with breast tumours